Ming‐Mo Hou
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 4
- Colorectal Cancer Treatments and Studies 4
-
- Palliative Care and End-of-Life Issues 12
- Co-authors
- Jen‐Shi Chen (19 shared papers)Wen‐Chi Chou (18 shared papers)Siew Tzuh Tang (17 shared papers)Wen‐Cheng Chang (17 shared papers)Yoon‐Koo Kang (7 shared papers)Chiun Hsu (4 shared papers)Fur‐Hsing Wen (16 shared papers)Masatoshi Kudo (5 shared papers)
- Journals
- Journal of Pain and Symptom Management (9 papers)Annals of Oncology (6 papers)Psycho-Oncology (4 papers)Journal of Clinical Oncology (3 papers)The Oncologist (2 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Ming‐Mo Hou
50 papers receiving 940 citations
Peers
Comparison fields: 5 of 74
- Hepatology 310
- Oncology 318
- Immunology 113
- Pathology and Forensic Medicine 83
- Cancer Research 67
Countries citing papers authored by Ming‐Mo Hou
This map shows the geographic impact of Ming‐Mo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Mo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Mo Hou more than expected).
Fields of papers citing papers by Ming‐Mo Hou
This network shows the impact of papers produced by Ming‐Mo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Mo Hou. The network helps show where Ming‐Mo Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Mo Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 189 | |
| 2 | 2019 | 179 | |
| 3 | 2015 | 53 | |
| 4 | 2021 | 41 | |
| 5 | 2017 | 39 | |
| 6 | 2016 | 37 | |
| 7 | 2020 | 25 | |
| 8 | 2016 | 24 | |
| 9 | 2017 | 22 | |
| 10 | 2017 | 22 | |
| 11 | 2018 | 20 | |
| 12 | 2019 | 19 | |
| 13 | 2024 | 18 | |
| 14 | 2021 | 17 | |
| 15 | Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma. | 2022 | 17 |
| 16 | 2021 | 16 | |
| 17 | Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platforms. | 2012 | 15 |
| 18 | 2018 | 15 | |
| 19 | 2016 | 13 | |
| 20 | 2018 | 13 |
About Ming‐Mo Hou
Ming‐Mo Hou is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine, Hepatology and Molecular Biology, having authored 52 papers that have together received 944 indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Ferroptosis and cancer prognosis (6 papers), CAR-T cell therapy research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Hepatology (310 citations), Oncology (318 citations), Immunology (113 citations), Pathology and Forensic Medicine (83 citations) and Cancer Research (67 citations). Ming‐Mo Hou has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Jen‐Shi Chen, Wen‐Chi Chou, Siew Tzuh Tang, Wen‐Cheng Chang, Yoon‐Koo Kang, Chiun Hsu, Fur‐Hsing Wen, Masatoshi Kudo, Tae‐You Kim and Chia‐Hsun Hsieh. Their work appears in journals such as Journal of Pain and Symptom Management, Annals of Oncology, Psycho-Oncology, Journal of Clinical Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.